Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin biomarker study in recently diagnosed colorectal cancer
2018-002101-65Phase 2Active
- Sponsor
- IIS Aragón
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aspirin in colorectal cancer (CRC), sponsored by IIS Aragón. Primary endpoint: Assessment of acetylation level of COX enzymes in platelets and colonic tissues. Started Jul 2018; status: active.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2018-002101-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002101-65.